
Health Dictionary
Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
EMCN
Introduction
Endomucin is a protein that in humans is encoded by the EMCN gene.[1][2][3] Endomucin is a marker for endothelial cells[4] and hematopoietic stem cells.[5]
Function
Function
EMCN is a mucin-like sialoglycoprotein that interferes with the assembly of focal adhesion complexes and inhibits interaction between cells and the extracellular matrix.[1][3]
References
References
- ↑ 1.0 1.1 Kinoshita M, Nakamura T, Ihara M, Haraguchi T, Hiraoka Y, Tashiro K, Noda M (June 2001). “Identification of human endomucin-1 and -2 as membrane-bound O-sialoglycoproteins with anti-adhesive activity”. FEBS Letters. 499 (1–2): 121–6. doi:10.1016/S0014-5793(01)02520-0. PMID 11418125.
- ↑ Liu C, Shao ZM, Zhang L, Beatty P, Sartippour M, Lane T, Livingston E, Nguyen M (October 2001). “Human endomucin is an endothelial marker”. Biochemical and Biophysical Research Communications. 288 (1): 129–36. doi:10.1006/bbrc.2001.5737. PMID 11594763.
- ↑ 3.0 3.1 “Entrez Gene: EMCN endomucin”.
- ↑ 1.Liu, C. et al. Human Endomucin Is an Endothelial Marker. Biochemical and Biophysical Research Communications 288, 129-136 (2001).
- ↑ Matsubara A.; et al. (2005). “Endomucin, a CD34-like sialomucin, marks hematopoietic stem cells throughout development”. Journal of Experimental Medicine. 11 (202): 1483. doi:10.1084/jem.20051325. PMC 2213340.
Further reading
Further reading
- Li G, Miles A, Line A, Rees RC (March 2004). “Identification of tumour antigens by serological analysis of cDNA expression cloning”. Cancer Immunology, Immunotherapy. 53 (3): 139–43. doi:10.1007/s00262-003-0471-y. PMID 14722670.
- Maruyama K, Sugano S (January 1994). “Oligo-capping: a simple method to replace the cap structure of eukaryotic mRNAs with oligoribonucleotides”. Gene. 138 (1–2): 171–4. doi:10.1016/0378-1119(94)90802-8. PMID 8125298.
- Suzuki Y, Yoshitomo-Nakagawa K, Maruyama K, Suyama A, Sugano S (October 1997). “Construction and characterization of a full length-enriched and a 5′-end-enriched cDNA library”. Gene. 200 (1–2): 149–56. doi:10.1016/S0378-1119(97)00411-3. PMID 9373149.
- Samulowitz U, Kuhn A, Brachtendorf G, Nawroth R, Braun A, Bankfalvi A, Böcker W, Vestweber D (May 2002). “Human endomucin: distribution pattern, expression on high endothelial venules, and decoration with the MECA-79 epitope”. The American Journal of Pathology. 160 (5): 1669–81. doi:10.1016/S0002-9440(10)61114-5. PMC 1850881. PMID 12000719.
- LinÄ“ A, StengrÄ“vics A, Slucka Z, Li G, Jankevics E, Rees RC (June 2002). “Serological identification and expression analysis of gastric cancer-associated genes”. British Journal of Cancer. 86 (11): 1824–30. doi:10.1038/sj.bjc.6600321. PMC 2375403. PMID 12087473.
- Kuhn A, Brachtendorf G, Kurth F, Sonntag M, Samulowitz U, Metze D, Vestweber D (December 2002). “Expression of endomucin, a novel endothelial sialomucin, in normal and diseased human skin”. The Journal of Investigative Dermatology. 119 (6): 1388–93. doi:10.1046/j.1523-1747.2002.19647.x. PMID 12485444.
- Kanda H, Tanaka T, Matsumoto M, Umemoto E, Ebisuno Y, Kinoshita M, Noda M, Kannagi R, Hirata T, Murai T, Fukuda M, Miyasaka M (September 2004). “Endomucin, a sialomucin expressed in high endothelial venules, supports L-selectin-mediated rolling”. International Immunology. 16 (9): 1265–74. doi:10.1093/intimm/dxh128. PMID 15249540.
- Reckzeh K.; Kizilkaya H.; Søgaard Helbo A.; Estruch Alrich M.; et al. (2018). “Human adult HSCs can be discriminated from lineage-committed HPCs by the expression of endomucin”. Blood Advances. 2: 1628–1632. doi:10.1182/bloodadvances.2018015743.</ref>
